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Abstract  
Recent research advancements in induced pluripotent stem cells (iPSCs) have 
broadened their capacity for research in specific disease models3, creating a 
need for effective and robust techniques to detect cell differentiation. Two 
techniques currently exist to determine cell type; morphology and 
immunostaining.  Although they have been used by researchers for many years, 
these methods can be unreliable, time-consuming, and very uneconomical.  We 
seek to create a technology that will be more accurate and efficient in detecting 
differentiation of iPSCs.  This will allow researchers greater speed in screening 
for specific differentiation products, further increasing the utility of iPSCs in 
medical research.  We will create an iPSC reporter cell line with the use of the 
Cas9/CRISPR associated novel genome editing technology.  We aim to generate 
a reporter cell line that expresses green fluorescent protein only after neural 
differentiation.  
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List of Figures 
 
Figure 1: Animation of Cas9 protein mechanism.  
Figure shows the mechanism of action for the Cas9 plasmid. It labels the gRNA, 
as well as the different sites within the DNA required for successful cleavage 
(Mali et al., 2013). 
 
Figure 2: Single GFP incorporation HEK293t cells before and after addition 
of Cas9.  
Microscope pictures were taken before (Top) and after (Bottom) introduction of 
the Cas9 protein. The HEK293t cell line was viewed under Bright Field 
Microscopy (BF) and under Fluorescence Microscopy (GFP). The pictures were 
merged for easier interpretation (Merged).  
 
Figure 3: Neuron Culture.  
Neurons viewed under Bright Field Microscopy (BF) and under Fluorescence 
Microscopy (FL). Fluorescent Microscopy highlights the red fluorescent antibody 
that is bound to β-III Tubulin. 
 
Figure 4: Example of promoter replacement process.  
Illustration describes the experimental process for replacing the pCBH promoter 
with a CAG promoter.  
 
Figure 5: Cas9 expression in HEK293 and iPSC cultures.  
After the addition of the Cas9 vector, HEK293 pictures were taken under Bright 
Field Microscopy (A) and under Fluorescent Microscopy (B). Pictures of the iPSC 
culture were also taken under Bright Field Microscopy (C) and Fluorescent 
Microscopy (D).  
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Introduction 
 
Background 
The characterization of a disease is key to understanding its effects in 
multicellular organisms. Therefore, disease pathophysiology has become a 
constant and essential influence on the medical field. The mechanisms and 
unique properties of distinct diseases are studied by utilizing the theories and 
techniques presented in biology, genetics, biochemistry, and bioengineering. The 
field has developed from simply understanding a disease, to understanding and 
treating the genetic disorder. The data collected in this field is used to develop 
novel pharmaceutics and specialized treatment therapies. Stem cells have been 
used to characterize many hereditary diseases and are a powerful tool for 
studying any genetically linked pathology.  
 
Human Derived Stem Cells (hSCs) 
 
Human derived stem cells (hSCs) are often used in disease biology. All types of 
human derived stem cells (hSCs) have two unique, useful properties:  
1. Naturally Immortalized Cell Line 
2. Pluripotency 
 
Naturally Immortalized: hSCs have the ability to infinitely proliferate or grow. 
Stem cells are able to continue to divide without the introduction of genetic 
mutations. Many cell types are not able to be cultured in the lab and often times 
the cell lines that are used are immortalized via genetic alteration or are derived 
from a cancerous source. An example of a difficult to culture cell line is neurons, 
the primary cell type in the brain.  
 
Pluripotency: Pluripotent cells have the unique ability of differentiating or 
changing to any cell type while maintaining the desired disease genotype. This 
feature is important because many types of tissues are hard to isolate and 
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culture. Stem cells are able to become any desired cell type by simply adding 
specific chemicals or growth factors.  
 
Induced Pluripotent Stem Cells (iPSCs) 
 
Induced pluripotent stem cells (iPSC) are even more powerful in studying 
disease pathophysiology. Induced pluripotent stem cells are derived from any 
normal somatic cell of a patient and will have all the unique properties of an hSC. 
Specific protein factors (Yamanaka Factors) are introduced to a somatic cell and 
reprogram it into its non-differentiated pluripotent state. This means that a single 
cell, such as a skin or blood cell, can be isolated from a diseased patient and can 
be induced into an iPSC. The iPSC can further be cultured and differentiated into 
the desired cell type and its phenotypic properties can be observed (Musunuru 
2013). As an example, we can consider the case of Cystic Fibrosis (CF), a 
genetic disease that affects lung tissue. A skin biopsy or blood sample of a 
patient with cystic fibrosis can be cultured and induced into a pluripotent stem 
cell. This iPSC can be differentiated into a lung cell and the disease can be 
observed. iPSCs are very versatile and give researchers the freedom of 
generating many different diseased cell lines.   
 
Determining Differentiation  
 
iPSC differentiation is not a definitive process and researchers are often given a 
mosaic of desired differentiated cells and undesired non-differentiated iPSCs. 
This leads to the need of a fast and effective way of determining one cell type 
from another. Currently there are two methods for determining cell differentiation: 
1. Morphology Observations  
2. Immunostaining  
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Morphology Observations:  Determining cell morphology requires hours of 
experience in cell culture. Cell morphology is determined via microscope and by 
observing certain attributes specific for each cell type. This can lead a researcher 
to label a cell an iPSC or a normal somatic cell.  
 
Immunostaining: This technique utilizes fluorescent antibodies to label specific 
proteins within a cell. Each cell expresses unique proteins that an antibody can 
bind to. Different cell types can be observed by using different colors of 
fluorescent antibodies.  
Neither of these techniques is efficient or cost-effective. Morphology 
observation can often be very unreliable and immunostaining require expensive 
reagents and antibodies. The process of identifying differentiated iPSC products 
would be greatly benefitted by the development of a method more robust than 
those that currently exist. 
 
Project Goal  
Herein, it is the overarching goal of this research project to engineer a reporter 
cell line that will “report” cell type specific differentiation events of iPSCs through 
expression of green fluorescent protein (GFP).  It is the goal of this research 
project to generate a stable reporter cell line by using the CRISPR/Cas9 genome 
editing technology. The generated iPSC cell line will “report” differentiation of 
iPSCs to specific cell types through expression of GFP. GFP expression will 
occur when the iPSCs are differentiated to the desired cell type. This is a multi-
layered project that requires completion of multiple sub projects. These projects 
will help create a reporter cell line. The projects include: 
 
1. Single incorporation of GFP into the genome of a mammalian cell line for 
Cas9 optimization 
2. Protocol optimization for neural differentiation of iPSCs 
3. Optimization of Cas9 plasmid for iPSC use 
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Single Incorporation 
of GFP into HEK293t 
Cells 
Neural 
Differentiation of 
iPSCs 
Optimization of Cas9 
Plasmid for iPSC 
Transfection 
Create a Stable 
Reporter Cell Line 
4. Create a stable reporter cell line by site specifically inserting GFP into the 
iPSC genome 
 
Success in the first three experiments will be essential to the successful 
generation of a stable reporter cell line. Although the fourth sub-project is the 
ultimate goal for this design project, success in either of the first three sub 
projects will be groundbreaking research. The scope of this project is very large 
and this report only covers the first three sub-projects. Production of the final 
Reporter Cell Line will still need to be conducted with further research. 
 
 
 
 
 
 
 
 
 
 
 
 
Significance  
As stated before, success in any area of this project will lead to significant 
research. The CRISPR/Cas9 genome editing technique we will be investigating 
and using is a relatively new genome editing technology. Any successful 
research generated dealing with the Cas9 protein will help elucidate its function 
and properties. Success in the overarching goal of this project will have a great 
impact on the stem cell industry and any industry that handles stem cells. The 
hypothesized reporter cell line could be engineered to report any type of iPSC 
differentiation product. This would be a powerful cell line that would help advance 
many biological fields.     
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Budget 
Item Vendor Unit Price Quantity Subtotal Sales Tax Shipping Total ($) 
mTeSR1 medium for 
human stem cell culture 
Stem Cell 
Technologies  
$272.00 2 $544.00 $48.96 $75.00 $667.96 
QIAprep Spin Miniprep 
Kit (250) 
Qiagen $367.00 1 $367.00 $33.03 $75.00 $475.03 
matrigel Basement 
Membrane Matrix  
Fisher 
Scientific 
$281.35 1 $281.35 $25.32 $50.00 $356.67 
Pippet tips RT-L10F Raining $82.66 1 $82.66 $7.44 $0.00 $90.10 
Pippet tips RT-L200F Raining $82.66 1 $82.66 $7.44 $0.00 $90.10 
Pippet tips RT-L1000F Raining $82.66 1 $82.66 $7.44 $0.00 $90.10 
Cell culture ware Fisher 
Scientific 
    $400.00 $32.00   $432.00 
              $2,201.96 
  BIOE 
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Chapter 1: 
Single Incorporation of GFP in HEK293t Cell for Cas9 Testing 
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Background & Significance 
 
CRISPR/CAS9 System  
There are many DNA editing technologies in current biotechnology. The 
clustered regularly interspaced short repeats (CRISPR) and CRISPR associated 
(Cas) system is the most novel and easily manipulated. The CRISPR/Cas 
system utilizes a complex of Cas proteins and guide RNAs (gRNA) to cut 
complementary double stranded DNA. Specifically, many researchers use the 
Cas9 protein; this protein was first isolated in the bacteria Streptococcus 
Pyogenes. Guide RNAs consist of a 20 base pair sequence matching the target 
DNA and an NGG adjacent motif. By simply changing the gRNA sequence, many 
different DNA sequences can be targeted (Cong et al., 2013). This system can 
effectively delete a targeted gene from the genome and can be used to insert 
genes into the genome by creating a double stranded break in DNA (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Animation of Cas9 protein mechanism. The 
above picture shows the mechanism of action for the Cas9 
plasmid. It labels the gRNA, as well as the different sites 
within the DNA required for successful cleavage (Mali et al., 
2013). 
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The CRISPR/Cas9 system will ultimately be used as the genome-editing tool for 
this project because of its higher efficiency compared to other genome editing 
technologies currently available. Zinc finger nucleases (ZFNs) and Transcription 
Activator-like Effector Nucleases (TALENs) are two competing genome-editing 
technologies. Although they are widely used in the biology field, the novel 
CRISPR/Cas system is simpler to engineer and is more efficient at introducing 
exogenous genes. Previous experiments have shown the CRISPR/Cas system is 
more efficient at introducing exogenous DNA than previous TALEN technologies 
(Mali et al., 2013). 
 
Significance of HEK293t Cell Line 
A human embryonic kidney (HEK293T) cell line with a single copy of GFP is 
imperative to prove the success of the CRISPR/Cas system. To test the 
efficiency of the Cas9 protein we first had it target the GFP gene. This enabled 
quantification of the Cas9 efficiency because successful cleavage correlates to 
loss of GFP fluorescence. However, most cells lines available were not 
compatible with this type of testing.  
 
Many current HEK293t GFP positive cells have multiple incorporations of GFP at 
unbiased sites. However, having multiple copies of GFP within the genome 
creates false positives while testing the CRISPR/Cas system; a cell will not stop 
fluorescing green after cleavage of one GFP gene because of multiple uncut 
copies still available to transcribe from. Multiple incorporations of GFP also pose 
problems during sequencing of the cut gene. Sequencing of the cut gene is 
important because the mechanism and location of the double stranded break 
also needs to be studied. Having a single GFP incorporation will solve these 
problems.  
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Sub-project Goals  
The CRISPR/Cas9 system is a relatively new system in biology and there are no 
definitive protocols for its use. The goal of this sub-project was to create a stable 
single incorporation GFP positive HEK293 cell line to test the Cas9 protein and to 
elucidate any problems within the system. The engineered HEK293t cell line was 
to serve as a model system to test the efficacy of the Cas9 protein at introducing 
double stranded breaks but was also going to be used to develop any necessary 
protocols to handle the Cas9 protein. Results of this project were to be analyzed 
and used for future use of the CRISPR/Cas system.   
 
Results 
We used both lentiviral and retroviral infection systems to incorporate GFP into 
the HEK293T genome. Virus transduction uses unique proteins to fully 
incorporate a desired gene into the genome; this is both robust and permanent. 
We tested different multiplicity of infections (MOIs) to determine a minimum MOI 
that would result in a single incorporation of GFP in HEK293t cells. We were able 
to isolate and freeze many different clones of our HEK293t cell line. Exact 
protocols can be found in Appendix C.  
 
We isolated a clone and cultured it until confluence and transfected the cells with 
a Cas9 protein that targeted the GFP gene. After 48 hours the culture was 
viewed under a fluorescent microscope to visualize GFP expression.  
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Discussion  
The goal of this subproject was to create a HEK293t cell line with a single 
integration of GFP. This cell line would have then served as a model system to 
test the Cas9 protein. The results of this subproject were suboptimal. The 
efficacy of the Cas9 protein is clearly visible and it indeed cleaved the GFP gene 
post treatment with Cas9 protein. However, GFP expression is still evident in the 
fluorescent microscopy and merged pictures after addition of the protein (Figure 
2). This leads us to conclude that this specific clone still possessed multiple 
copies of the GFP gene. Therefore, single incorporation was not successful. 
Quantitative Polymerase Chain Reaction (QPCR) analysis was inconclusive and 
could not confirm nor deny our claims (Data Not Shown). Many single 
incorporation HEK293t cell clones were created but were not tested. We believe 
Figure 2. Single GFP incorporation HEK293t cells before and after addition 
of Cas9. Microscope pictures were taken before (Top) and after (Bottom) 
introduction of the Cas9 protein. The HEK293t cell line was viewed under Bright 
Field Microscopy (BF) and under Fluorescence Microscopy (GFP). The pictures 
were merged for easier interpretation (Merged).  
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one of the clones will have a single incorporation of GFP and in the future this 
cell line can be used to further test the CRISPR/Cas system and its respective 
protocols.  
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Chapter 2: 
Protocol Optimization for Neural Differentiation of iPSCs 
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Background & Significance  
 
hESC Neural Differentiation  
iPSCs have the unique ability to differentiate into any type of cell and researchers 
can influence the differentiation by supplementing the cell culture with 
appropriate growth factors, proteins, or small molecules. One such protein is the 
Noggin protein; it is one of the few factors that will induce neural differentiation of 
hESCs. The Noggin protein inhibits the Transforming Growth Factor beta (TGF-
β) signaling pathway by inhibiting another protein named Bone Morphogenic 
Protein (BMP4) (Lim et al., 2000). It is known that the inhibition of this specific 
pathway leads to neural progenitor differentiation. Like many other differentiation 
protocols, hESCs can be differentiated to specific cell types by adding different 
proteins. 
 
Alstem Bio has developed and tested a protocol for differentiation of iPSCs to 
neural stem cells. This protocol uses a variety of soluble factors, such as noggin, 
and culture techniques to coax the iPSCs towards a neural stem cell fate. It is 
important to know how to both handle iPSCs and how to differentiate them. 
These are both extremely difficult processes that require extensive cell culture 
training.   
 
Sub-Project Goals 
The goal of this sub-project was to get familiar with iPSC maintenance and 
differentiation protocols. We also optimized the neural differentiation protocols 
that were developed by Alstem. The experience we gained while culturing the 
iPSCs and executing the differentiation protocol will be very useful in conducting 
the final stage of the project.  
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Results 
We were able to culture and differentiate iPSCs by following Alstem’s protocols 
on iPSC maintenance and neural differentiation (Appendix B). We were able to 
successfully culture an iPSCs for many passages and were also able to 
differentiate them into neural stem cells. After differentiation we followed an 
immunostaining protocol (provided by Alstem) to mark β-III Tubulin, a neuron 
specific marker.  
 
 
Discussion  
We were able to successfully differentiate iPSCs into neurons. Fluorescent 
microscopy and immunostaining techniques were able to confirm the expression 
of the neuron specific protein β-III Tubulin; this indicated successful 
differentiation of iPSCs to neurons (Figure 3). These protocols and techniques 
can be applied in the future when handling the final step of this project. 
 
 
 
 
Figure 3. Neuron Culture. Neurons viewed under Bright Field Microscopy 
(BF) and under Fluorescence Microscopy (FL). Fluorescent Microscopy 
highlights the red fluorescent antibody that is bound to β-III Tubulin. 
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Chapter 3: 
Optimization of Cas9 Plasmid 
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Background & Significance 
 
Cas9 Promoter Region 
The Cas9 plasmid is commercially available for research purposes. The vector 
contains all the necessary genetic features to apply the Cas9 plasmid to genomic 
DNA. A map of its components can be found in Appendix A. Every transgenic 
vector will contain its individual exogenous promoter; this promoter is necessary 
for the expression of the genes within the vector. However, not all promoters are 
created equal. Some promoters will help promote higher protein expression.  
 
As stated earlier in this report, iPSCs are a very difficult cell type to experiment 
with and choosing the optimal iPSC promoter is no exception. The original Cas9 
plasmid contains only a Chicken β-Actin Promoter (pCBh). This promoter has 
been shown to express proteins only in normal cell types (i.e. HEK293t cells) but 
will not drive expression of proteins within hESCs or iPSCs. A suitable 
replacement for the pCBh promoter is a CAG promoter. The CAG promoter 
consists of three genetic components that will help drive expression of proteins 
within a hESC. Its components include a Cytomegalovirus (CMV) enhancer, a 
Chicken-β-actin promoter, and a Rabbit β-Globulin Splice acceptor gene. 
Previous studies have shown that the stronger CAG promoter will help promote 
expression of transgenic genes within hESCs (Chen et. al., 2011).  
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Sub-Project Goals 
The goal of this subproject was to successfully incorporate a CAG promoter on 
the Cas9 Plasmid and successfully express Cas9 in iPSCs. We used common 
molecular cloning techniques that utilize polymerase chain reaction (PCR), 
restriction enzymes, and ligation protocols.  
 
 
 
Figure 4. Example of promoter replacement process. The above illustration 
describes the experimental process for replacing the pCBH promoter with a CAG 
promoter.  
 
Results  
Normal ligation protocols were followed to transfer the CAG promoter in the Cas9 
vector and the primers used to amplify the CAG can be found in Appendix D. 
Additionally a GFP gene was added to the Cas9 vector so that a fusion 
GFP+Cas9 protein would be expressed. This allowed for visualization and 
qualification of the Cas9 protein. The eventual vector was transfected in HEK293 
cells as well as iPSCs to test its efficacy at promoting Cas9 expression.  
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Discussion  
Expression of the Cas9 protein is vital in our eventual experiment design so 
successful Cas9 expression was imperative. After the transfection of the newly 
acquired plasmid in HEK293t cells, we saw high amounts of protein expression 
but more importantly the proteins were being localized in the nucleus (Figure 5 
A&B). The reason for the localization was because of a Nuclear Localization 
Sequence within the vector but the localization is important because close 
proximity of the Cas9 protein and DNA is vital. After the transfection into iPSCs 
we saw much less expression of the protein (Figure 5 C&D) but although the 
expression of the protein was very low, there would be no protein expression if 
the vector had its original pCBh promoter (Data Not Shown). We believe the low 
readings of GFP are due to transfection rather than expression efficiencies. 
Usually iPSC cultures are cultured at a very low density; however, the iPSC 
culture we transfected the new Cas9 vector into was very dense. This could have 
Figure 5. Cas9 expression in HEK293 and iPSC cultures. 
After the addition of the Cas9 vector, HEK293 pictures were 
taken under Bright Field Microscopy (A) and under 
Fluorescent Microscopy (B). Pictures of the iPSC culture were 
also taken under Bright Field Microscopy (C) and Fluorescent 
Microscopy (D).  
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led to the low transfection efficiency of the vector into the cell. Therefore, the 
iPSCs visualized above may not all obtain the correct vector. It is important to 
realize that the proteins that are actually being expressed are also being 
localized within the nucleus. Therefore this sub-project elucidates three important 
things: the new vector is working and expressing the correct proteins (Figure 5 
B), the Cas9 protein is being localized within the nucleus (Figure 5 B&D), and the 
new vector promotes Cas9 protein expression within iPSCs (Figure 5 D). This 
vector is vital for future research and can be further engineered to create the final 
Reporter Cell Line.  
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Chapter 4: 
Create a Stable iPSC Reporter Cell Line 
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Background 
 
Neural Cell Lineage and Nestin Protein Expression  
The Nestin promoter region will be targeted as the site for GFP incorporation. 
Nestin is a protein that is expressed purely in neural stem cells and is an ideal 
area to integrate a reporter gene like GFP.  A gRNA will be designed to target the 
Nestin promoter region and the CRISPR/Cas system will create a double 
stranded break within that region. Through homologous recombination a copy of 
the GFP gene will be incorporated in the area where the break occurs. 
Homologous recombination has been previously used in tandem with the 
CRISPR/Cas system to incorporate GFP in a genome.  More than 8% of cells 
can successfully be incorporated with GFP through CRISPR/Cas cutting and HR. 
Expression of Nestin in the event of neural stem cell generation will be coupled 
with expression of GFP by inserting GFP in conjunction with the Nestin gene. 
The high expression of GFP within a cell will indicate the expression of Nestin 
and therefore indicate a neural cell lineage.  
 
Sub-Project Goals 
Successful incorporation of GFP after the Nestin promoter will be the final goal of 
this project. A stable cell line will have been created that will fluoresce after 
neural differentiation.  Successful creation of the iPSC reporter cell for neural 
stem cell differentiation will more importantly represent success in using the 
Cas9 genome-editing tool to improve upon current methods of detecting iPSC 
differentiation.  Should this project be successful, it could be theoretically applied 
to any possible differentiation product of iPSCs, given that an expression specific 
gene exists for each cell line. This method will ultimately help save time and 
resources for future differentiation of iPSCs.  
  
 
 
 
  BIOE 
24 
 
Conclusions and Implications 
 
Design Outcome 
Our experimental design is an attempt at producing a more user-friendly line of 
iPSCs. In development of our iPSC reporter cell line method of detecting cell 
type, we worked to produce a line of HEK293t’s with a single integration of GFP 
and to optimize the Cas9 vector for expression in iPSCs.  These supporting 
milestone projects are key research and development advances, and they also 
greatly contribute to the development of the novel CRISPR/Cas9 system and to 
its optimization in different applications. 
 
Successful generation of the HEK293t line with a single integration of GFP was 
inconclusive based on qPCR testing of one isolated colony.  Many colonies 
however, were isolated that showed GFP expression after viral transfection, and 
it is highly likely that qPCR analysis of these will find a successful single 
integration.  This qPCR analysis is a lengthy process and could not be completed 
by the submission of this report.   
 
By integrating the CAG promoter into the Cas9 vector, we made it possible for 
Cas9 to be expressed in stem cells for the first time.  pCBh is not expressed by 
stem cells, including iPSCs, so it was necessary to exchange this promoter for 
CAG in the CRISPR/Cas9 plasmid, which is expressed in iPSCs.  This new 
plasmid was sequenced and tested for expression in HEK293t and in iPSCs.  It 
was found that the pCAG CRISPR/Cas9 plasmid was expressed in both cell 
lines.  
 
Testing of Alstem’s neural stem cell differentiation protocol for iPSCs allowed us 
an opportunity to optimize and become familiar with the methods of the protocol 
before having to perform these experiments in testing our reporter cell line.  
These test protocols were successful, and we also learned how to grow and 
handle the very sensitive iPSC line. 
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The progress made in this senior design project is very important in the 
development of the novel iPSC reporter cell line method of detecting 
differentiation, and has also resulted in further development of the CRISPR/Cas9 
genome editing tool.  This new reporter cell line method will allow customers to 
accurately differentiate unlimited amounts of a single target cell line for use in 
their own research projects.  Our product starts with neural stem cell 
differentiation, however there exciting possibilities for the inclusion of other cell 
lines in future iPSC reporter cell line versions.  Much work will need to be done 
before this idea can be finally tested, but the results thus far have been very 
promising, and work will continue.  Ultimately, this research will lead to greater 
use of iPSCs in medical research through the iPSC reporter cell line, and to 
greater use of the CRISPR/Cas9 system in iPSCs and other stem cell lines. 
 
 
Future Work 
Although many advances were made in the course of this project, we did not 
create our final iPSC reporter cell line and several steps lie ahead before the 
product will be functional.  First, the CRISPR/Cas9 plasmid we have that targets 
GFP must be tested in the single integration line of HEK293t-GFP.  After the 
HEK293t isolate with single integration GFP is located, we will apply the Cas9 
plasmid and visualize the number of cells that cease to express green 
fluorescence.  This is an important step because the plasmid for Cas9 has been 
rebuilt and must be retested to assure that the function of the system has not 
been negatively affected.  This will allow us to determine the accuracy and 
efficiency with which Cas9 cleaves the GFP gene, a result that should parallel 
the action of Cas9 cutting near Nestin in iPSCs.   
 
If experimentation in the HEK293t-GFP model is successful, then our 
CRISPR/Cas9 system will be applied to iPSCs.  This will be done in the presence 
of GFP in order to incorporate the GFP gene into the Cas9 genome near Nestin.  
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Those colonies that show the greatest GFP fluorescence in their nuclei during 
Cas9 expression (Cas9 will be labeled with GFP during DNA cleavage) will then 
need to be isolated and sequenced to determine insert success.  Isolates with 
successful GFP gene insertion will then be subjected to a neural stem cell 
differentiation protocol to test if the GFP signal is automatic and accurate.  
Accuracy of fluorescent neural stem cell signaling from cells in culture will be 
determined through sequencing and comparison with immunostaining. 
 
This new reporter cell line method will allow customers to accurately differentiate 
unlimited amounts of a single target cell line for use in their own research 
projects.  Our product starts with neural stem cell differentiation, however there 
are exciting possibilities for the inclusion of other cell lines in future iPSC reporter 
cell line versions.  For other cell lines to benefit from this technology, we will need 
to identify a gene in each cell line that can serve as its trademark of 
differentiation; a gene that only that type of cell will express.  For the cell lines 
that have such an associated gene, we have two options to consider in creating 
an iPSC line that reports their differentiation; 1) produce a line of reporter iPSCs 
that reports the differentiation of a single cell-type, and 2) produce a line of 
reporter iPSCs that reports the differentiation of more than one cell-type.  The 
second option would require the incorporation of fluorescent markers of varying 
color, but leads to the idea that eventually the Cas9 system could be used to 
create a single master line of iPSCs that reports the differentiation of many very 
useful cell lines.  This work also opens the door for further application of the 
Cas9/CRISPR system as a genome editing tool in iPSCs.  Creative minds will 
surely push the application of this technology in currently unforeseen directions. 
 
Ethics & Global Health 
Although our product will not have a direct impact on society, as it and its 
products are not intended for use by most citizens, it is meant to help solve 
medical afflictions affecting people around the world. Novel diseases such as 
cancer and AIDS plague the global population, but a cure to these diseases 
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could be discovered through the knowledge acquired by research of disease 
biology. The customers of our product will be research institutes, but the 
research they conduct will produce therapies that could affect global 
communities. We believe this to be ethically positive because it aligns with two of 
the Ethical Standards put forth in the Santa Clara University “Framework for 
Thinking Ethically”4 and one of the Articles of “The Universal Declaration of 
Human Rights.” 5  
 
Disease biology ultimately serves utilitarian and common good approach to 
ethics. Our project will lead a field that will provide “the greatest good and [do] 
the least harm”4 to a global society. Disease biology solves the pertinent issues 
in global disease and provides hope to otherwise condemned individuals. While 
there may be some ethical concerns regarding methodology in the field of 
disease biology, human health will be greatly increased through its research. 
Disease biology is important because it creates “common conditions that are 
important to the welfare of everyone.”4 The sick and weary will be cared for and 
their ailments will be solved through the research conducted in this field. 
 
The disease biology field also adheres to the 27th article of “The Universal 
Declaration of Human Rights.” This article states, “Everyone has the right to 
freely participate in the cultural life of the community, to enjoy the arts and to 
share in scientific advancement and its benefits.”5 Disease biology will cure sick 
individuals who would not be able to participate in cultural life and give them the 
opportunity to receive treatment resulting from scientific advancement. 
  
The field of disease biology seeks to use diseased patient’s cells to model 
different types of disease. Very useful iPSC lines can be engineered by obtaining 
a biopsy of a patient’s skin or other cell type. Our project deals with increasing 
the efficiency of this process. However, we acknowledge the ethical issues 
involved in this modeling approach.  
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Patients are essentially giving away their property when they donate their cells 
for disease modeling. These cells are engineered into an iPSC line that is usually 
sold commercially. These cell lines also contain the genetic information that is 
unique to the individual who donated it. These two qualities present ethical 
dilemmas within this field. A person has the right to “be treated as ends and not 
merely as means to other ends.”4 This approach to studying disease biology 
violates a person’s rights and can therefore be seen as unethical if their right to 
self-property is not respected.  
 
A paper titled “Ethical issues arising from the participation of children in genetic 
research”6 discussed the uses of these types of models. A patient’s rights need 
to be protected and “special attention should be placed on recruitment 
procedures, informed consent, and confidentiality protections.”3 Adults are able 
to provide researchers with their consent, thereby not violating any of their rights. 
Children’s cells are also often used in this type of research. A child may not have 
the ability to fully understand their rights and will likely have a parent make a 
decision for them. “Re-consent of pediatric participants when they reach 
adulthood,”3 will ensure the protection of even a child’s rights in use of their cells 
for disease biology.   
 
Economics & Manufacturability 
One of the driving forces behind this project is the advantage it will have over 
immunostaining in terms of economic feasibility.  Our projected budget for this 
project is around $2200, not including facilities fees.  In the event that our method 
is expanded to other cell lines, these funds will again need to be allocated to 
allow for development of the new reporter cell line.  Once a reporter cell line is 
developed though, its only expense is in its upkeep, which consists mainly of 
feeding the cells and the facilities charges for their storage.  This cost could 
easily be passed down to customers by charging them for the sale and use of the 
reporter cell lines.  Immunostaining is a process that must be repeated each time 
you wish to know a cell’s type, using up kits that cost from $300-$800.  The cost 
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of development of a single reporter cell line could easily be diluted across many 
customers over a number of years, making the reporter cell line likely to be much 
less expensive than an immunostaining kit. 
 
One challenge that exists for the iPSC reporter cell line is in its large-scale 
manufacturing.  There aren’t any companies in the world that can mass produce 
stem cells of any type due to their sensitivity to culture conditions.  Many 
companies do large-scale cultures of other mammalian cells, like HEK and CHO, 
but these cells serve as production vehicles themselves, synthesizing valuable 
molecules within their plasma membrane such as a therapeutic protein that is 
then purified from the cellular debris.  The livelihood and quality of the iPSC must 
be maintained with high fidelity throughout their lifecyle in order for them to 
remain valuable reporters of cellular differentiation, so current production 
methods will simply not do for our new product.  The creation of such 
manufacturing methods is a very complex undertaking, and should be left to a 
well-established biotechnology company with a broad support base in finances 
and employee expertise.  For our product, we will need to rely on the production 
quality of the same small culture rooms in which we are now developing the 
reporter cell line for neural stem cells.  Growth in use of the technology will allow 
growth in size of the company that is selling it, allowing growth in their facilities 
and growth in production.  iPSCs are a sensitive but very valuable product of 
medical research, and must be treated for the time being with great care and 
intimacy in production.  
 
Social Impacts 
Although the end goal of this project is to create a reporter cell line for detection 
of cell-specific differentiation, a side product of our research will be the 
development of Cas9, a genome editing tool.  Genome editing has proven to be 
a topic of hot discussion, primarily because it imparts the capacity for creativity in 
creation of biological life forms.  Citizen-popular media sources love to 
extrapolate the potential of such far-reaching technologies, especially into 
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discussions on reproduction.  The ability to influence the characteristics of a 
person through manipulation of their germ line scares and angers many people, 
especially in the United States where religion is still a key player in influencing 
public opinion.  There is the potential for fallout over the further development of a 
genomic editing tool like Cas9, which could be used to delete or insert genes in a 
germ line.  This potential is even greater considering that we are optimizing the 
Cas9 for use in cell types that carry the germ line genetic information in a 
developing embryo, making crossover of the technology into procreation that 
much more feasible.  If it gains enough attention, the expansion of reporter cell 
line technology could be prevented by public uprising against further 
development of genomic editing tools, much as it did for stem cell research. 
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Appendix A.Picture of px260 vector and all genetic components. This is a 
picture of the genetic components of the cas9 vector used in the experimental 
process.  
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Appedix B. Protocols for iPSC maintanance and dffierentiation into  
neurons. Protocols set by Alstem Bio.  
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Appendix C. Protocols For Cloning of Single Incorporation GFP HEK293t 
cells.  
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Appendix D. Primer design for CAG amplification.  
 
 
PCR1: for 5' CAG promoter 
 
pCAG-5S KpnI:  
 
5'-AGA G GTAC C - GTC GAC ATT GAT TAT TGA CTA GTT ATT-3' 
 
pCAG-5A BamHI: 
 
5'-CA CCT CGA G GATC C - TAA TAG CGA TGA CTA ATA CGT AGA TG-3' 
 
 
Template 1: pCXEL-RFP-Puro 
 
----------------------------------------------------------------- 
PCR2 for 3' CAG promoter 
 
pCAG-3S BamHI: 
 
5'-G CTA TTA G GATC C - TCG AGG TGA GCC CCA CGT TCT G-3' 
 
 
pCAG-3A NcoI: 
 
5'-AGT C CATG G TGG C - AGA GCC GCC GGT CAC ACG CCA GAA G-3' 
 
 
Template 2: pCXEL-RFP-Puro 
 
----------------------------------------------------------------- 
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PCR3 for full CAG promoter: 
 
pCAG-5S KpnI: 
 
5'-AGA G GTAC C - GTC GAC ATT GAT TAT TGA CTA GTT ATT-3' 
 
pCAG-3A NcoI: 
 
5'-AGT C CATG G TGG C - AGA GCC GCC GGT CAC ACG CCA GAA G-3' 
 
 
Template 3: PCR products of PCR1 + PCR2 (1 ul out of 50 ul each) 
 
 
------------------------------------------------------------------ 
 
Digest vector pX260-U6-DR-BB-DR-Cbh-NLS-hSpCas9-NLS-H1-shorttracr-
PGK-puro and PCR3 product with KpnI and NcoI enzyme in 1x NEBuffer 
1.1, then ligate them. 
 
